Will benefit managers jump in with Cigna's move to pull OxyContin?

If Cigna's foray into abuse-deterrent opioids is a success, other payors may follow suit. On Wednesday, Cigna Corp. (NYSE: CI) announced it would no longer cover OxyContin, the opioid painkiller manufactured by Purdue Pharma LP, starting in January. Instead, Cigna will offer Xtampza ER through a "value-based contract" with Collegium Pharmaceutical Inc. While both OxyContin and Xtampza are oxycodone products, Xtampza is supposed to deter drug abuse by remaining an extended-release drug even when…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news